Villanueva UGIB transfusion trial
Transfusion strategies for acute upper gastrointestinal bleeding
On this page
Overview
In acute upper GI bleeding, restrictive transfusion at Hb <7 g/dL improved survival compared with a liberal Hb <9 g/dL strategy.
Clinical takeaway
This trial supports restrictive transfusion in most UGIB patients, with caution in exsanguinating bleeding or active ischemic heart disease.
Key result
45-day mortality was 5% with restrictive vs 9% with liberal transfusion (HR 0.55).
Practice impact
Restrictive transfusion became standard in UGIB resuscitation once immediate instability is addressed.
Evidence
Study design
Single-center randomized controlled trial.
Enrollment
921
Follow-up
45 days.
Geography
Spain
Clinical question
Does restrictive transfusion improve outcomes in acute upper GI bleeding?
Population
- Patients with severe acute upper gastrointestinal bleeding (including peptic ulcer and variceal sources).
Intervention
Restrictive transfusion: transfuse at Hb <7 g/dL, target 7-9 g/dL.
Comparator
Liberal transfusion: transfuse at Hb <9 g/dL, target 9-11 g/dL.
Primary outcome
Death from any cause within 45 days.
A restrictive transfusion threshold (Hb 7 g/dL) improved 45-day survival and reduced rebleeding compared with a liberal strategy in acute upper GI bleeding.
Hazard ratio / 0.55 / CI 95% CI 0.33-0.92 / p=0.02
Key results
- 45-day mortality: 5% with restrictive vs 9% with liberal transfusion; HR 0.55 (95% CI 0.33-0.92; p=0.02).
- Further bleeding: 10% vs 16% (p=0.01).
- The survival benefit was significant in patients with cirrhosis and Child-Pugh class A or B disease.
- Restrictive transfusion blunted the rise in portal pressure in cirrhotic patients.
Harms
- Adverse events overall were fewer with the restrictive strategy.
- Liberal transfusion was associated with more rebleeding and, in cirrhosis, higher portal pressures.
Clinical Use
When to cite
- When choosing a restrictive transfusion strategy for upper GI bleeding after initial stabilization.
Practice impact
- Restrictive transfusion became standard in UGIB resuscitation once immediate instability is addressed.
Applicability
- Most applicable to patients with severe acute upper gastrointestinal bleeding.
Limitations
- Single-center trial that excluded massive exsanguinating bleeding and acute coronary syndrome/stroke.
- Clinical instability and active ischemia can override numeric thresholds.
- Endoscopy was performed early (within 6 hours), which may not reflect all practice settings.
Common misinterpretations
- The restrictive threshold applies after initial hemodynamic stabilization, not during brisk ongoing exsanguination.
- Benefit was especially clear in cirrhosis, where over-transfusion raises portal pressure and provokes rebleeding.
Related evidence
Citation
Villanueva C, Colomo A, Bosch A, et al. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med. 2013;368(1):11-21. doi:10.1056/NEJMoa1211801
As compared with a liberal transfusion strategy, a restrictive strategy significantly improved outcomes in patients with acute upper gastrointestinal bleeding.
- PMID
- 23281973